AMINOSYN 7% (PH6) Drug Patent Profile
✉ Email this page to a colleague
When do Aminosyn 7% (ph6) patents expire, and when can generic versions of Aminosyn 7% (ph6) launch?
Aminosyn 7% (ph6) is a drug marketed by Icu Medical Inc and is included in one NDA.
The generic ingredient in AMINOSYN 7% (PH6) is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminosyn 7% (ph6)
A generic version of AMINOSYN 7% (PH6) was approved as amino acids by B BRAUN on April 13th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINOSYN 7% (PH6)?
- What are the global sales for AMINOSYN 7% (PH6)?
- What is Average Wholesale Price for AMINOSYN 7% (PH6)?
Summary for AMINOSYN 7% (PH6)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | AMINOSYN 7% (PH6) at DailyMed |
-patent-expirations.png "AMINOSYN 7% (PH6) drug patent expirations")
US Patents and Regulatory Information for AMINOSYN 7% (PH6)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Icu Medical Inc | AMINOSYN 7% (PH6) | amino acids | INJECTABLE;INJECTION | 017673-006 | Nov 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
